Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV

Author(s): Stephen L. Gwaltney II

Volume 8, Issue 17, 2008

Page: [1545 - 1552] Pages: 8

DOI: 10.2174/156802608786413519

Price: $65

Abstract

Inhibitors of dipeptidyl peptidase IV (DPP-4) have emerged as an important new class of therapeutic agents for type two diabetes. Various medicinal chemistry approaches have been applied to this area and have resulted in the identification of numerous late-stage development compounds. The discoveries of several of the most advanced DPP-4 inhibitors are reviewed.

Keywords: Dipeptidyl Peptidase IV (DPP-4), Glucagon-like Peptide-1 (GLP-1), vildagliptin (Galvus®), saxagliptin (Onglyza™), sitagliptin (Januvia™), linagliptin (Ondero®), alogliptin


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy